Financial Year |
March 31 2023 |
Monetary Funds |
978,009,029.38 |
Held-for-trading Financial Assets |
803,343,790.39 |
Notes Receivable |
15,006,933.00 |
Accounts Receivable |
76,246,389.37 |
Advances to Suppliers |
2,518,784.07 |
Other Receivables |
19,014,198.12 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
591,833,543.92 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
208,000.00 |
Other Current Assets |
29,399,757.89 |
Total Current Assets |
2,515,580,426.14 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,040,000.00 |
Long-term Equity Investment |
2,789,242,849.02 |
Investment Properties |
1,820,223,348.80 |
Fixed Assetes |
19,594,942.04 |
Under-construction Projects |
1,684,803,169.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
411,152,935.51 |
R&D expenses |
-- |
Goodwill |
52,947,108.05 |
Long-Term Deferred and Prepaid Expenses |
533,285,288.13 |
Deferred Income Tax Assets |
244,413,273.41 |
Other Non-Current Assets |
136,065,092.25 |
Sub-Total of Non-Current Assets |
9,769,015,787.06 |
Total Assets |
12,284,596,213.20 |
Short-Term Loans |
285,484,125.35 |
Trading Financial liabilities |
-- |
Notes Payable |
96,001,721.07 |
Accounts Payable |
357,956,096.67 |
Accounts Received In Advance |
50,615,379.39 |
Employee Compensation Payable |
25,910,447.86 |
Taxes Payable |
55,548,545.91 |
Interest Payable |
-- |
Dividend Payable |
4,382,271.97 |
Other payables |
613,351,250.46 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
598,930,682.18 |
Other Current Liabilities |
165,198,544.44 |
Sub-Total of Current Liabilities |
2,254,685,192.99 |
Long-term Loans |
323,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
26,299,974.31 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
87,609,262.10 |
Other Non-Current Liabilities |
121,417,055.89 |
Sub-Total of Non-Current Liabilities |
3,077,862,989.18 |
Total Liabilities |
5,332,548,182.17 |
Paid-In Capital(Or Share Stock) |
2,737,351,947.00 |
Capital Surplus |
4,653,838,038.01 |
Surplus Reserve |
76,469,525.04 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-621,654,093.83 |
Minority Stockholder's Interest |
21,018,358.92 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,931,029,672.11 |
Owner's Equity(Stockholder's Equity) |
6,952,048,031.03 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,284,596,213.20 |